Quality Chemical Industries Limited (QCIL)

Quality Chemical Industries Limited (QCIL), formerly known as Cipla Quality Chemical Industries Limited (CiplaQCIL), is a prominent pharmaceutical manufacturing company based in Luzira, Kampala, Uganda. Established in 2005, the company is a leading producer of WHO-prequalified HIV/AIDS and malaria treatments in Sub-Saharan Africa, with a strong focus on producing affordable essential medicines. The company operates a state-of-the-art facility that manufactures a wide range of oral solid dosage forms, including antiretrovirals (ARVs), artemisinin-based combination therapies (ACTs) for malaria, and treatments for Hepatitis B, tuberculosis, and other conditions. QCIL serves multiple African markets and is committed to enhancing healthcare access through local manufacturing, sustainability, and adherence to stringent international quality standards.